CTGF Inhibits BMP-7 Signaling in Diabetic Nephropathy
- 1 November 2008
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 19 (11) , 2098-2107
Abstract
In diabetic nephropathy, connective tissue growth factor (CTGF) is upregulated and bone morphogenetic protein 7 (BMP-7) is downregulated. CTGF is known to inhibit BMP-4, but similar cross-talk between BMP-7 and CTGF has not been studied. In this study, it was hypothesized that CTGF acts as an inhibitor of BMP-7 signaling activity in diabetic nephropathy. Compared with diabetic wild-type CTGF+/+ mice, diabetic CTGF+/− mice had approximately 50% lower CTGF mRNA and protein, less severe albuminuria, no thickening of the glomerular basement membrane, and preserved matrix metalloproteinase (MMP) activity. Although the amount of BMP-7 mRNA was similar in the kidneys of diabetic CTGF+/+ and CTGF+/− mice, phosphorylation of the BMP signal transduction protein Smad1/5 and expression of the BMP target gene Id1 were lower in diabetic CTGF+/+ mice. Moreover, renal Id1 mRNA expression correlated with albuminuria (R = −0.86) and MMP activity (R = 0.76). In normoglycemic mice, intraperitoneal injection of CTGF led to a decrease of pSmad1/5 in the renal cortex. In cultured renal glomerular and tubulointerstitial cells, CTGF diminished BMP-7 signaling activity, evidenced by lower levels of pSmad1/5, Id1 mRNA, and BMP-responsive element–luciferase activity. Co-immunoprecipitation, solid-phase binding assay, and surface plasmon resonance analysis showed that CTGF binds BMP-7 with high affinity (Kd approximately 14 nM). In conclusion, upregulation of CTGF inhibits BMP-7 signal transduction in the diabetic kidney and contributes to altered gene transcription, reduced MMP activity, glomerular basement membrane thickening, and albuminuria, all of which are hallmarks of diabetic nephropathy.Keywords
This publication has 39 references indexed in Scilit:
- Renal Fibrosis and Glomerulosclerosis in a New Mouse Model of Diabetic Nephropathy and Its Regression by Bone Morphogenic Protein-7 and Advanced Glycation End Product InhibitorsDiabetes, 2007
- A Critical Look at Growth Factors and Epithelial-to-Mesenchymal Transition in the Adult KidneyNephron Experimental Nephrology, 2006
- Urinary Connective Tissue Growth Factor Excretion Correlates With Clinical Markers of Renal Disease in a Large Population of Type 1 Diabetic Patients With Diabetic NephropathyDiabetes Care, 2006
- Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: Preliminary reportKidney International, 2003
- Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-βNature Cell Biology, 2002
- In vitro evidence for differential involvement of CTGF, TGFβ, and PDGF‐BB in mesangial response to injuryNephrology Dialysis Transplantation, 2001
- Expression of connective tissue growth factor in human renal fibrosisKidney International, 1998
- A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye.Genes & Development, 1995
- HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidneyKidney International, 1994
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991